OZEVICA Trademark

Trademark Overview

On Tuesday, April 12, 2016, a trademark application was filed for OZEVICA with the United States Patent and Trademark Office. The USPTO has given the OZEVICA trademark a serial number of 86972406. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 26, 2024. This trademark is owned by Celgene Corporation. The OZEVICA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of leukemia, auto inflammatory disease, autoimmune disease, blood disease, cancer, multiple sclerosis, ulcerative colitis, arthritis, musculoskeletal and skin diseases; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
ozevica

General Information

Serial Number86972406
Word MarkOZEVICA
Filing DateTuesday, April 12, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 26, 2024
Registration Number5239306
Registration DateTuesday, July 11, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 25, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the treatment of leukemia, auto inflammatory disease, autoimmune disease, blood disease, cancer, multiple sclerosis, ulcerative colitis, arthritis, musculoskeletal and skin diseases; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 26, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Friday, January 26, 2024CANCELLED SEC. 8 (6-YR)
Friday, December 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, December 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 9, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, December 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, July 11, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 11, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, April 25, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 25, 2017PUBLISHED FOR OPPOSITION
Wednesday, April 5, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 17, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, March 9, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 9, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 9, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 3, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, February 28, 2017SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, August 15, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, August 15, 2016LETTER OF SUSPENSION E-MAILED
Monday, August 15, 2016SUSPENSION LETTER WRITTEN
Friday, August 12, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 12, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, August 6, 2016ASSIGNED TO LIE
Friday, July 29, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 28, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 28, 2016NON-FINAL ACTION E-MAILED
Thursday, July 28, 2016NON-FINAL ACTION WRITTEN
Friday, July 22, 2016ASSIGNED TO EXAMINER
Friday, April 15, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 15, 2016NEW APPLICATION ENTERED

Related Keywords

ozevica pharmaceutical disease preparations namely diseases skin cytokine musculoskeletal inhibitory immune